TAKE Limited

TAKE Limited

11.50
INR
+0.13
(+1.14%)
0.39EPS
64.70P/E
3.74BMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
67.96
60.87
85.81
105.46
120.62
139.53
151.34
52.93
44.63
12.93
0.25
- -
3.7
5.56
Basic EPS, GAAP
4.83
5.82
9.97
11.22
12.19
12.13
-0.85
-30.91
-53.5
-6.86
-8.18
2.53
0.74
0.39
Free Cash Flow per Basic Share
2.18
3.81
-0.26
-7.2
-1.91
2.71
1.96
9.03
6.09
-0.85
0.1
-1.11
-0.28
- -
Dividend per Share
1
1
1.23
1.03
1
1.94
0.49
- -
- -
- -
- -
- -
0.02
- -
Book Value per Share
39.17
42.84
53.13
68.37
89.79
102.63
107.73
76.03
12.38
7.43
-0.61
1.4
2.1
- -
Tangible Book Value per Share
13.67
19.32
17.7
37.87
61.56
43.99
46.51
28.27
8.53
3.71
-0.73
1.4
2.1
- -
Basic Weighted Avg Shares
120
120
120
127
132
146
146
146
146
146
146
148
147
152
Sales/Revenue/Turnover
8,155
7,304
10,301
13,446
15,872
20,390
22,129
7,740
6,526
1,891
36
- -
542
846
Operating Margin (%)
8.63
12.35
13.54
13.17
12.81
11.35
0.8
-19.37
-9.21
3.08
-181.04
- -
-3.55
-2.24
Depreciation Expense
373
203
248
874
1,041
1,535
1,669
1,154
959
168
79
- -
- -
- -
Net Income, GAAP
580
699
1,197
1,431
1,605
1,773
-124
-4,520
-7,823
-1,003
-1,196
375
108
59
Effective Tax Rate (%)
1.59
6.37
13.86
11.44
14.96
17.29
- -
- -
- -
- -
- -
- -
3.63
- -
Profit Margin (%)
7.11
9.57
11.62
10.64
10.11
8.7
-0.56
-58.4
-119.86
-53.03
-3,320.93
- -
20.02
7.03
Working Capital
1,993
2,091
1,895
4,435
7,630
4,482
5,391
3,366
796
-107
-539
76
185
- -
LT Debt
576
8
676
488
545
389
2,127
1,613
278
139
66
- -
- -
- -
Total Equity
5,183
5,805
6,792
9,532
13,367
15,274
15,854
11,243
1,806
1,086
-89
205
310
- -
Return on Invested Capital (%)
10.25
12.05
15.56
14.15
12.16
10.26
- -
- -
- -
- -
- -
-29.01
-6.74
- -
Return on Capital (%)
9.14
9.22
13.63
13.71
12.07
10.41
- -
- -
- -
- -
- -
161.79
43.41
- -
Return on Common Equity (%)
13.03
14.05
20.59
18.48
14.33
12.46
-0.8
-33.48
-119.82
-69.23
- -
- -
42.11
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
146
148
148
Market Capitalization
5,840
5,861
3,741

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
238
- -
Cash, Cash Equivalents & STI
- -
184
- -
Accounts Receivable, Net
- -
2
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
52
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-44.27%
-102.46%
51.02%
Free Cash Flow
121.77%
-320.31%
-74.79%
Net Income, GAAP
329.52%
-39.44%
-71.04%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
794.36%

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
542
542
2027
304
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
-0.26
-0.11
3.26
-0.33
2.53
2026
-0.04
- -
0.07
0.29
0.74
2027
0.07
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
0.02
2027
- -
- -
- -
- -
- -

Company Description

CEO
Vandana Gupta
Full Time Employees
5
Sector
Technology services
Industry
Information technology services
Address
No. 27, Tank Bund Road Chennai TN India 600102
IPO Date
Aug 29, 2007
Business
TAKE Solutions Limited, operating alongside its various divisions, delivers specialized services and technology-driven platforms for the life sciences and supply chain management sectors across North America, the Asia Pacific, and European markets. The company concentrates on providing comprehensive clinical development services, encompassing full-spectrum clinical research, data management, and generics support, including advanced bioavailability and bioequivalence studies. Under its Navitas Life Sciences brand, it offers expertise in navigating regulatory pathways, ensuring compliance, and managing pharmacovigilance and safety protocols. Furthermore, TAKE Solutions extends its capabilities into digital healthcare through artificial intelligence and machine learning for medical decision-making, along with cloud adoption and mobile solutions aimed at patient-centricity, payer insights, and sophisticated medical device technologies. Within supply chain management, the firm provides niche engineering, collaboration tools, and product re-engineering services, utilizing proprietary technology to streamline logistics and enhance compliance. The clientele comprises a diverse range of innovator biopharmaceutical and medical device enterprises, alongside generics producers, and governmental health organizations. Established in 2000, TAKE Solutions Limited maintains its principal offices in Chennai, India, and functions as a publicly traded entity with significant oversight from TAKE Solutions Pte. Limited.